167 related articles for article (PubMed ID: 37208608)
1. CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
Xu D; Liu X; Ke S; Guo Y; Zhu C; Cao H
BMC Cancer; 2023 May; 23(1):464. PubMed ID: 37208608
[TBL] [Abstract][Full Text] [Related]
2. CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.
Zhou S; Shen Z; Wang Y; Ma H; Xu S; Qin J; Chen L; Tao H; Zhen Z; Chen G; Zhang Z; Li R; Xiao H; Zhong C; Yang Y; Liang C
PLoS One; 2013; 8(9):e74430. PubMed ID: 24040244
[TBL] [Abstract][Full Text] [Related]
3. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway.
Zhou R; Sun J; He C; Huang C; Yu H
Hum Cell; 2020 Oct; 33(4):1120-1132. PubMed ID: 32564199
[TBL] [Abstract][Full Text] [Related]
4. Naive Treg-like CCR7(+) mononuclear cells indicate unfavorable prognosis in hepatocellular carcinoma.
Shi JY; Duan M; Sun QM; Yang L; Wang ZC; Mynbaev OA; He YF; Wang LY; Zhou J; Tang QQ; Cao Y; Fan J; Wang XY; Gao Q
Tumour Biol; 2016 Jul; 37(7):9909-17. PubMed ID: 26813566
[TBL] [Abstract][Full Text] [Related]
5. Increased tumor-infiltrating CD45RA
Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
[TBL] [Abstract][Full Text] [Related]
6. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Ma R; Guan X; Teng N; Du Y; Ou S; Li X
BMC Med Genomics; 2023 Oct; 16(1):254. PubMed ID: 37864213
[TBL] [Abstract][Full Text] [Related]
7. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis].
Chen B; Lu LM; Tao L; Zhou L; Li SM; Zhu L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):759-64. PubMed ID: 21092675
[TBL] [Abstract][Full Text] [Related]
9. Seminal fluid regulates accumulation of FOXP3+ regulatory T cells in the preimplantation mouse uterus through expanding the FOXP3+ cell pool and CCL19-mediated recruitment.
Guerin LR; Moldenhauer LM; Prins JR; Bromfield JJ; Hayball JD; Robertson SA
Biol Reprod; 2011 Aug; 85(2):397-408. PubMed ID: 21389340
[TBL] [Abstract][Full Text] [Related]
10. CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma.
Schomer NT; Jiang ZK; Lloyd MI; Klingemann H; Boissel L
Cytotherapy; 2022 Aug; 24(8):827-834. PubMed ID: 35400595
[TBL] [Abstract][Full Text] [Related]
11. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
Xu B; Zhou M; Qiu W; Ye J; Feng Q
Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
Nandagopal S; Wu D; Lin F
PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944
[TBL] [Abstract][Full Text] [Related]
13. CCL19 enhances CD8
Yan Y; Zhao W; Liu W; Li Y; Wang X; Xun J; Davgadorj C
J Gastroenterol; 2021 Aug; 56(8):769-785. PubMed ID: 34218330
[TBL] [Abstract][Full Text] [Related]
14. PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.
Muthuswamy R; Mueller-Berghaus J; Haberkorn U; Reinhart TA; Schadendorf D; Kalinski P
Blood; 2010 Sep; 116(9):1454-9. PubMed ID: 20498301
[TBL] [Abstract][Full Text] [Related]
15. CCR7 signaling inhibits T cell proliferation.
Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 is up-regulated by CCL19/CCR7 interaction via PI3K/Akt pathway and is involved in CCL19-driven BMSCs migration.
Zhang W; Tu G; Lv C; Long J; Cong L; Han Y
Biochem Biophys Res Commun; 2014 Aug; 451(2):222-8. PubMed ID: 25086360
[TBL] [Abstract][Full Text] [Related]
17. CCR7-CCL19/CCL21 Axis is Essential for Effective Arteriogenesis in a Murine Model of Hindlimb Ischemia.
Nossent AY; Bastiaansen AJ; Peters EA; de Vries MR; Aref Z; Welten SM; de Jager SC; van der Pouw Kraan TC; Quax PH
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275068
[TBL] [Abstract][Full Text] [Related]
18. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
19. The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.
Peng C; Zhou K; An S; Yang J
Tumour Biol; 2015 Jan; 36(1):329-35. PubMed ID: 25256673
[TBL] [Abstract][Full Text] [Related]
20. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.
Cai W; Tao J; Zhang X; Tian X; Liu T; Feng X; Bai J; Yan C; Han Y
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1933-41. PubMed ID: 24990231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
